title: Modelling the regenerative niche: a major challenge in biomaterials research.
abstract: By definition, biomaterials are developed for clinical application. In the field of regenerative medicine their principal function is to play a significant, and, if possible, an instructive role in tissue healing. In the last analysis the latter involves targeting the 'regenerative niche'. The present paper will address the problem of simulating this niche in the laboratory and adopts a life science approach involving the harnessing of heterotypic cellular communication to achieve this, that is, the ability of cells of different types to mutually influence cellular functions. Thus, co-culture systems using human cells are the methodological focus and will concern four exemplary fields of regeneration, namely, bone, soft tissue, lower respiratory tract and airway regeneration. The working hypothesis underlying this approach is that in vitro models of higher complexity will be more clinically relevant than simple monolayer cultures of transformed cell lines in testing innovative strategies with biomaterials for regeneration.
authors.affiliation: REPAIR-Lab, Institute of Pathology, University Medical Center, Johannes Gutenberg University Mainz, D-55101 Mainz, Germany;; Department of Biomaterials, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
authors.forename: C James
authors.initials: CJ
authors.lastname: Kirkpatrick
keywords: biomaterial–cell interaction; regenerative mechanism; stem cells
references.citation: Lab Invest. 2004 Jun;84(6):736-52
references.pmid: 15077120
references.citation: Exp Cell Res. 2013 Oct 1;319(16):2460-9
references.pmid: 23856376
references.citation: Biomaterials. 2008 Nov;29(32):4306-13
references.pmid: 18706689
references.citation: Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):291-9
references.pmid: 21281686
references.citation: Nat Med. 2014 Aug;20(8):857-69
references.pmid: 25100531
references.citation: Tissue Eng Part A. 2014 May;20(9-10):1355-7
references.pmid: 24597500
references.citation: J Tissue Eng Regen Med. 2015 Jun 15;:null
references.pmid: 26078119
references.citation: Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):367-74
references.pmid: 21295094
references.citation: Adv Ther. 2014 Aug;31(8):817-36
references.pmid: 25069580
references.citation: Eur J Pharm Biopharm. 2013 Jun;84(2):275-87
references.pmid: 23183446
references.citation: Nat Cell Biol. 2011 May;13(5):513-8
references.pmid: 21540847
references.citation: Tissue Eng Part A. 2014 Oct;20(19-20):2656-65
references.pmid: 24684395
references.citation: J Cell Physiol. 2010 Nov;225(2):348-53
references.pmid: 20626000
references.citation: Science. 1997 Feb 14;275(5302):964-7
references.pmid: 9020076
references.citation: Tissue Eng Part C Methods. 2015 Sep;21(9):909-21
references.pmid: 25782021
references.citation: Nat Med. 2013 Apr;19(4):413-5
references.pmid: 23558630
references.citation: Beilstein J Nanotechnol. 2015 Feb 20;6:517-28
references.pmid: 25821694
references.citation: Semin Pediatr Surg. 2014 Jun;23(3):119-26
references.pmid: 24994525
references.citation: J Tissue Eng Regen Med. 2015 Feb;9(2):85-105
references.pmid: 23166000
references.citation: Stem Cell Rev. 2011 Jun;7(2):248-55
references.pmid: 21052872
references.citation: Biomaterials. 2004 Sep;25(21):5137-46
references.pmid: 15109837
references.citation: J R Soc Interface. 2010 Feb 6;7 Suppl 1:S41-54
references.pmid: 19793744
references.citation: Biomaterials. 2004 Mar;25(6):1069-75
references.pmid: 14615172
references.citation: Eur J Pharm Biopharm. 2009 Jun;72(2):339-49
references.pmid: 18762254
references.citation: Biomaterials. 2007 Jan;28(2):240-8
references.pmid: 16945411
references.citation: Biomaterials. 2007 Dec;28(34):5193-8
references.pmid: 17761278
references.citation: Endocrinology. 2002 Apr;143(4):1545-53
references.pmid: 11897714
references.citation: J Biomech. 2014 Jun 27;47(9):2173-82
references.pmid: 24239005
references.citation: Nature. 1988 Mar 31;332(6163):411-5
references.pmid: 2451132
references.citation: Trends Biotechnol. 2008 Apr;26(4):166-72
references.pmid: 18261813
references.citation: J Clin Invest. 2000 Jan;105(1):71-7
references.pmid: 10619863
references.citation: Eur J Cardiothorac Surg. 1998 Dec;14(6):621-3
references.pmid: 9879875
references.citation: Cell Tissue Res. 2009 Apr;336(1):91-105
references.pmid: 19238447
references.citation: Calcif Tissue Int. 1997 Apr;60(4):368-74
references.pmid: 9075635
references.citation: Biomaterials. 2007 Sep;28(27):3965-76
references.pmid: 17582491
references.citation: Tissue Eng Part A. 2011 Sep;17(17-18):2199-212
references.pmid: 21529248
references.citation: Nat Biotechnol. 2014 Aug;32(8):795-803
references.pmid: 25093887
references.citation: Artif Organs. 2006 Oct;30(10):822-7
references.pmid: 17026583
references.citation: Part Fibre Toxicol. 2011 Jan 27;8(1):6
references.pmid: 21272353
references.citation: J Cell Biochem. 1997 Dec 1;67(3):386-96
references.pmid: 9361193
references.citation: Biomaterials. 2002 Aug;23(16):3413-9
references.pmid: 12099284
references.citation: Eur Cell Mater. 2014 Feb 19;27:149-64; discussion 164-5
references.pmid: 24554272
references.citation: Biomaterials. 2012 May;33(14 ):3662-72
references.pmid: 22349289
references.citation: Stem Cells Int. 2015;2015:728307
references.pmid: 25810726